Skip to main content
. 2010 Feb 2;15(2):182–186. doi: 10.1634/theoncologist.2009-0297

Figure 1.

Figure 1.

Factors that may play a role in determining the inherent resistance of CML leukemia-initiating cells to imatinib.

Abbreviations: ABCG2, ATP-dependent transporter cassette protein G2; CML, chronic myeloid leukemia; CXCR4, CXC chemokine receptor 4.